Subscribe (Free) to
Daily or Weekly Newsletters
Post a Job

Featured Jobs

Remittance Specialist

Daybright Financial
(Rochester NY / Fort Walton Beach FL / Hybrid)

Daybright Financial logo

Actuary

The Pension Source
(Remote / Stuart FL / Abilene TX)

The Pension Source logo

Consulting Actuary

Daybright Financial
(Remote)

Daybright Financial logo

Plan Consultant - DB/CB

MAP Retirement
(Remote)

MAP Retirement logo

Quality Review Specialist

MAP Retirement
(Remote)

MAP Retirement logo

Retirement Plan Consultant

MAP Retirement
(Remote)

MAP Retirement logo

Senior Counsel – Investment Solutions

Great Gray Trust Company
(Remote / Boston MA / Wilmington DE / Las Vegas NV / DC / FL / NC / NY / Hybrid)

Great Gray Trust Company logo

Distribution Reviewer

Nova 401(k) Associates
(Remote)

Nova 401(k) Associates logo

Regional Vice President, Sales

MAP Retirement
(Remote)

MAP Retirement logo

Retirement Plan Consultant

The MandMarblestone Group, llc
(Remote)

The MandMarblestone Group, llc logo

Senior Retirement Plan Administrator (TPA)

Public Accounting Firm
(Eugene OR / Bend OR / Corvallis OR / Lake Oswego OR / Hybrid)

Retirement Relationship Manager

MAP Retirement
(Remote)

MAP Retirement logo

Participant Support Representative

Daybright Financial
(Rochester NY / Hybrid)

Daybright Financial logo

Senior Plan Consultant, Defined Benefit

DWC - The 401(k) Experts
(Remote)

DWC - The 401(k) Experts logo

View More Employee Benefits Jobs

Free Newsletters

“BenefitsLink continues to be the most valuable resource we have at the firm.”

-- An attorney subscriber

Mobile app icon
LinkedIn icon     Twitter icon     Facebook icon

FTC's 'Landmark' Settlement with Pharmacy Benefit Manager Express Scripts: Impact on Pharma
King & Spalding Link to more items from this source
Feb. 10, 2026

"Two remedial measures agreed to by ESI could particularly impact pharmaceutical manufacturers: [1] ESI's commitment not to discriminate between high and low list price versions of the same drug, and [2] delinking administrative fees paid by manufacturers from the list price.... [It] is unclear how ESI and the other PBMs will negotiate rebates for high and low list price drugs going forward."  MORE >>

Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title).
An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above).